Authors: Rennard, SI Anderson, W ZuWallack, R Broughton, J Bailey, W Friedman, M Wisniewski, M Rickard, K

Citation: Si. Rennard et al., Use of a long-acting inhaled beta(2)-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease, AM J R CRIT, 163(5), 2001, pp. 1087-1092

Authors: Nathan, RA ZuWallack, R

Citation: Ra. Nathan et R. Zuwallack, Fluticasone and cortisol measurements, CHEST, 119(3), 2001, pp. 984-985

Authors: Affleck, G Apter, A Tennen, H Reisine, S Barrows, E Willard, A Unger, J ZuWallack, R

Citation: G. Affleck et al., Mood states associated with transitory changes in asthma symptoms and peakexpiratory flow, PSYCHOS MED, 62(1), 2000, pp. 61-68

Authors: ZuWallack, R Adelglass, J Clifford, DP Duke, SP Wire, PD Faris, M Harding, SM

Citation: R. Zuwallack et al., Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma, CHEST, 118(2), 2000, pp. 303-312